Korsana Biosciences KRSA
NASDAQ KRSA
$34.00 +3.17 (+10.28%)
At close: Sep 29, 2026 · 4:00 PM EDT

Korsana Biosciences (KRSA) Share-based Compensation (2018 - 2025)

Updated

Korsana Biosciences' Share-based Compensation came in at $118,000 for Q3 2025, down 14.5% from $138,000 a year earlier but up 3.5% from the prior quarter.

Analysis

Korsana Biosciences (KRSA) Share-based Compensation (2018 - 2025) Analysis & Trends

Over the trailing twelve months to Sep 30, 2025, Korsana Biosciences reported Share-based Compensation of $468,000, down 22.8% year-over-year; for FY2024, it was $625,000, down 41.4% from FY2023.

  • Share-based Compensation has declined in each of the last five years, with a five-year compound annual growth rate of -49.8% (FY2019 to FY2024).
  • Going back by year, Share-based Compensation was $1.07 million in FY2023 (-82.9%), $6.25 million in FY2022 (-34.9%), $9.61 million in FY2021 (-35.9%) and $14.99 million in FY2020 (-23.6%).
  • The five-year range for quarterly Share-based Compensation is $103,000 (Q4 2023) to $3.21 million (Q4 2020).
  • Year-over-year, Share-based Compensation has declined for three consecutive quarters, with an average decline of 35.5% over the last eight quarters.
  • The fastest year-over-year change in Share-based Compensation over five years came in Q4 2024 (growth of 18.4%), and the weakest in Q4 2023 (a decline of 90.8%).
  • Business Quant data shows KRSA's Share-based Compensation at $114,000 (Q2 2025), $114,000 (Q1 2025) and $122,000 (Q4 2024) in the three quarters before Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 Korsana Biosciences 16.27 Mn 1.82 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 118,000.00
Jun 30, 2025 114,000.00
Mar 31, 2025 114,000.00
Dec 31, 2024 122,000.00
Sep 30, 2024 138,000.00
Jun 30, 2024 184,000.00
Mar 31, 2024 181,000.00
Dec 31, 2023 103,000.00
Sep 30, 2023 159,000.00
Jun 30, 2023 379,000.00
Mar 31, 2023 426,000.00
Dec 31, 2022 1.12 Mn
Sep 30, 2022 1.66 Mn
Jun 30, 2022 1.70 Mn
Mar 31, 2022 1.77 Mn
Dec 31, 2021 2.55 Mn
Sep 30, 2021 2.41 Mn
Jun 30, 2021 2.34 Mn
Mar 31, 2021 2.31 Mn
Dec 31, 2020 3.21 Mn
API Access

Korsana Biosciences Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=KRSA&period=max&api_key=YOUR_API_KEY